Carlos Alcaraz has been wearing nasal strips in some matches since last season. That's sparked an interest in the ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Spray it ain’t so! It’s bad enough you’re brushing your teeth all wrong — now it turns out you’ve also been abusing your nasal spray. “I was yesterday years old when I learned there ...

Nasal spray H5N1 avian influenza vaccine developed Date: April 8, 2025 Source: The University of Hong Kong Summary: Scientists have pioneered an influenza virus vector-based nasal spray vaccine ...

The study is published in Nature Communications. During the early COVID-19 pandemic, this platform enabled the rapid development of a nasal spray vaccine in collaboration with mainland China's ...

Last year, the U.S. Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 pounds or more, and this month it approved a lower dose spray for ...

Free naloxone nasal spray is offered in Ontario, Quebec, the Yukon and Northwest Territories. Unlike the more invasive injectable version, the overdose-reversing medication is sprayed directly ...

Nasal spray shows preclinical promise for treating traumatic brain injury. ScienceDaily . Retrieved May 28, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250227125519.htm ...

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...

The US Food and Drug Administration (FDA) has approved the use of esketamine nasal spray as a standalone treatment for adults with major depressive disorder (MDD) who have not responded adequately ...

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...